+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism



Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism



Translational Research 156(6): 350-357



Wilson disease is an autosomal recessive disorder with copper metabolism. In Japan, the standard treatment is the administration of copper chelating agents, such as D-penicillamine and trientine. In this study, the authors used zinc acetate to treat Japanese patients with Wilson disease and investigated its efficacy. The 37 patients that comprise this study were found to have Wilson disease using clinical and biochemical tests and were administrated zinc acetate for 48 weeks. The authors followed the clinical symptoms and laboratory findings of the patients by assessing their complete blood counts, biochemical findings, as well as the results of urinalysis and special laboratory tests for copper and zinc metabolism. We also examined side effects of the treatment. Zinc acetate did not aggravate the hepatic or neurological symptoms of any of the patients. Blood biochemical analysis also did not reveal elevation of alanine aminotransferase, aspartate aminotransferase, and γ-glutamyltranspeptidase levels. Zinc treatment did not aggravate the patients' clinical signs and/or laboratory findings. However, it did improve some clinical symptoms of the Wilson disease patients. Although this agent had some side effects, none of them were severe. The authors measured spot urinary copper excretion, which gave an indication of the efficacy of treatment and of the sufficient dosage of zinc. We recommend maintaining a spot urinary copper excretion less than 0.075-μg/mg creatinine. The authors conclude that zinc acetate is an effective and safe treatment for Japanese patients with Wilson disease.

(PDF emailed within 0-6 h: $19.90)

Accession: 052874295

Download citation: RISBibTeXText

PMID: 21078496

DOI: 10.1016/j.trsl.2010.08.007


Related references

Changes in zinc metabolism during long-term D-penicillamine treatment of patients with Wilson-Konovalov disease. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 84(3): 356-359, 1984

Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment. Journal of Inherited Metabolic Disease 2018, 2018

Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment. Journal of Inherited Metabolic Disease 2019, 2019

Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate. Journal of Neurology 243(3): 269-273, 1996

Long-term effects of a combination of D-penicillamine and zinc salts in the treatment of Wilson's disease in children. Experimental and Therapeutic Medicine 5(4): 1129-1132, 2013

The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease. Acta Hepato-Gastroenterologica 22(5): 292-296, 1975

The treatment of Wilson's disease with zinc. IV. Efficacy monitoring using urine and plasma copper. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 184(4): 446-455, 1987

Effects of long-term phenytoin treatment on brain weight and zinc and copper metabolism in rats. Neurochemical Pathology 5(2): 87-106, 1986

Studies on copper metabolism. XXIX. A critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease. American Journal of Medicine 28: 555-563, 1960

Studies on copper metabolism. 29. A critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease. Amer. J. Med, 28: 553-563, 1960

Comparative metabolism of copper and zinc in patients with Wilson's disease (hepatolenticular degeneration). American Journal of the Medical Sciences 254(1): 13-23, 1967

Treatment of Wilson's disease with zinc: XV long-term follow-up studies. Journal of Laboratory and Clinical Medicine 132(4): 264-278, 1998

Correction of copper metabolism is not sustained long term in Wilson's disease mice post bone marrow transplantation. Hepatology International 2(1): 72-79, 2008

Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine. Die Medizinische Welt 32(3): 109-110, 1981

Treatment with D-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease. Biometals 27(1): 207-215, 2015